Search Results
Dec 15, 2025, 12:04 ET Africa Emerges as Gold's Next Supply Engine Amid Record Prices and Development Wave
https://www.mining.com/web/south-africa-opens-rare-new-gold-mine-after-record-price-rally/ Logo -
More news about: USA News Group
Dec 15, 2025, 12:01 ET Firstsource announces leadership changes to accelerate growth across Healthcare Payer and Provider businesses
strategic differentiation for Firstsource. With a strong, well-diversified presence across both payer and provider segments, Firstsource brings a rare, end-to-end perspective across the healthcare value chain. As the portfolio continues to expand in both scale and complexity, the introduction of two
More news about: Firstsource
Dec 15, 2025, 09:30 ET Survey: As AI Drives Electricity Demand, Environmental Sustainability Remains a Low Priority in Corporate AI Strategies
advanced AI components or recover critical minerals at scale.Critical-mineral dependence: AI hardware relies on cobalt, nickel, copper, rare earths, gallium, and germanium—all linked to significant land, water, and biodiversity impacts.3—AI Applications for SustainabilityAI
More news about: The Conference Board
Dec 15, 2025, 09:01 ET JustPaid Accelerates Growth with 4 Strategic Partnerships
delivers the level of sophistication you'd expect from an enterprise platform, but at a price that actually makes sense for growing companies. It's rare to find a solution that's both powerful and cost-effective, and JustPaid has struck that balance perfectly," says Eric Davis, Co-Founder and CEO
More news about: Just Paid
Dec 15, 2025, 08:37 ET Morphy's Dec. 16-18 Firearms & Militaria Auction Is a Virtual Arsenal of Premier Sporting Guns, Rare NFA and Other Prized Military Weapons
multimedia:https://www.prnewswire.com/news-releases/morphys-dec-16-18-firearms--militaria-auction-is-a-virtual-arsenal-of-premier-sporting-guns-rare-nfa-and-other-prized-military-weapons-302642275.htmlSOURCE
More news about: Morphy Auctions
Dec 15, 2025, 08:02 ET Fondazione Telethon and Orphan Therapeutics Accelerator Sign Memorandum of Understanding to Pioneer Non-Profit Commercial Access Model for Ultra-Rare Disease Gene Therapy in the US
clinical-stage treatments for ultra-rare conditions to patients, and Fondazione Telethon (FT), an Italian non-profit with a 30-year+ legacy of advancing research on rare and complex genetic diseases, today
More news about: Orphan Therapeutics Accelerator; Fondazione Telethon
Dec 15, 2025, 08:01 ET Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission
is a commercial stage U.S.-based biopharmaceutical company focused on bringing innovative therapies to patients living with rare diseases. Recognized for its commitment to the rare disease community, Sentynl leverages its global operations as well as its parent organization, Zydus Group, to advance the
More news about: Sentynl Therapeutics
Dec 15, 2025, 08:00 ET Immusoft Secures FDA Orphan Drug Designation for ISP-002 in MPS II, a Progressive Lysosomal Storage Disease
the Company's investigational engineered B cell therapy for the treatment of mucopolysaccharidosis type II (MPS II), also known as Hunter syndrome, a rare and life-threatening lysosomal storage disorder.
More news about: Immusoft
Dec 15, 2025, 08:00 ET Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
life.Sobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK
More news about: Arthrosi Therapeutics
Dec 15, 2025, 07:00 ET Vanda Announces Submission of Biologics License Application to the FDA for Imsidolimab for the Treatment of Generalized Pustular Psoriasis
maintenance study period with monthly doses. Imsidolimab demonstrated a favorable safety profile with no clinically meaningful safety signals.GPP is a rare, chronic, life-threatening autoinflammatory skin disorder characterized by sudden flares of widespread pustules, erythema, and systemic symptoms such
More news about: Vanda Pharmaceuticals Inc.
Dec 15, 2025, 07:00 ET 1-800-Packouts names Tim Williamson as new Vice President of Operations
high-performing teams positions him to strengthen the operational foundation of 1-800-Packouts as the brand continues its rapid growth."Tim brings a rare blend of franchise expertise, operational discipline and entrepreneurial leadership," said Stefan Figley, President of 1-800-Packouts. "He understands
More news about: 1-800-Packouts
Dec 15, 2025, 03:00 ET Nintendo Switch (TM) Game, "The Battle Cats Unite!" of PONOS Corp., Surpasses 1.6 Million Global Downloads
progress in-game, they will have the opportunity to play one of four different mini-games. Players can earn a high score to get special in-game items and rare tickets.Long-awaited free update availableA new update has been released with the features below.*To download the update, players
More news about: PONOS Corporation
Dec 15, 2025, 03:00 ET Medit Announces 2025 Year-End Promotion
30%.Limited-Time Promotion Through the End of 2025This promotion is only available through the end of the year, offering dental professionals a rare opportunity to experience Medit's latest innovations and upgrade their clinical workflows at exceptional value. All benefits are time-limited and will
More news about: Medit
Dec 15, 2025, 03:00 ET Medit annonce sa promotion de fin d'année 2025
de l'année 2025Disponible uniquement jusqu'à la fin de l'année, cette promotion constitue pour les professionnels de la santé dentaire une rare occasion de découvrir les dernières innovations de Medit et d'améliorer leur flux de travail clinique à un prix exceptionnel. Tous les avantages sont
More news about: Medit
Dec 15, 2025, 02:00 ET DMX-200 ACTION3 PHASE 3 TRIAL COMPLETES RECRUITMENT
successfully completed, reflecting the commitment and operational excellence of the Dimerix team and our clinical partners. Achieving this milestone in a rare disease setting reflects our ability to execute efficiently in complex environments. With patient data now being collected across a 2-year treatment
More news about: Dimerix
Dec 15, 2025, 01:28 ET Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
SobiSobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK
More news about: Viva Biotech
Dec 15, 2025, 01:06 ET Viva Biotech's invested and incubated company, Arthrosi, has entered into an acquisition agreement with Sobi for a total transaction value of up to US$1.5 billion.
SobiSobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK
More news about: Viva Biotech
Dec 14, 2025, 16:42 ET Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually
resulting from use of whole-genome sequencing (WGS) combined with MyOme's AI-integrated risk models (IRMs) for common, chronic conditions, cancers, and rare disease.
More news about: MyOme, Inc
Dec 13, 2025, 19:00 ET ZAKSIMLAB Set to Launch Cabbage-Based Electrolyte Drink, Signaling New Innovation in the Functional Beverage Market
export initiatives as it positions itself as a global wellness brand.A ZAKSIMLAB official commented, "A cabbage-based electrolyte drink is a rare and innovative addition to the electrolyte beverage category," adding, "This launch will further solidify our identity as a wellness brand rooted in
More news about: ZAKSIMLAB
Dec 13, 2025, 15:57 ET Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
life.Sobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Dec 13, 2025, 15:52 ET Sobi to acquire Arthrosi Therapeutics, strengthening pipeline for the potential treatment of gout
life.Sobi®Sobi is a global biopharma company unlocking the potential of breakthrough innovations, transforming everyday life for people living with rare diseases. Sobi has approximately 1,900 employees across Europe, North America, the Middle East, Asia and Australia. In 2024, revenue amounted to SEK
More news about: Swedish Orphan Biovitrum AB
Dec 12, 2025, 11:58 ET Shark Tank's Kevin Harrington Interviews Monument Metals CEO Jonathan Swyers: Building Trust in Precious Metals
and headquartered in Frederick, Md., Monument Metals is an e-commerce retailer specializing in gold, silver, platinum and palladium bullion as well as rare coins. Known for competitive pricing, swift nationwide fulfillment and award-winning customer service, Monument Metals holds an A+ rating with the Better
More news about: Monument Metals
Dec 12, 2025, 11:15 ET Is Christmas Going Luxury? A New Trend Emerges with the 18K-Gold Heirloom Edition of 'Twas the Night Before Christmas
The release comes as affluent consumers increasingly seek rare, meaningful, handcrafted pieces that stand apart from mass-produced holiday goods. In the same way couture fashion houses and prestige watchmakers have
More news about: Twas
Dec 12, 2025, 11:14 ET Breaux Law Firm Co-Owner Evan Breaux Warns of 'Systematic Erosion' of Victim Rights Under New Louisiana Tort Laws
eliminated this right. "For decades, Louisianans had a straightforward path to accountability. Now, that path is gone," Breaux lamented. "Except in very rare circumstances, victims are now forced into a convoluted process of suing an individual first. This creates delays and expenses that only benefit the
More news about: Breaux Law Firm
Dec 12, 2025, 10:47 ET Pancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
from marketed products being invested into oncology and rare disease programs."Over the next three years, we expect to build a large seasonal vaccine franchise for at-risk populations and invest the cash generated into oncology and rare disease therapeutics," said Stéphane Bancel, CEO of Moderna.
More news about: USA News Group